Classification
- Anatomical main groupAAlimentary tract and metabolism
- Therapeutic subgroupA04
- Pharmacological subgroupA04A
- Chemical subgroupA04AA
- Chemical substanceA04AA01Ondansetron
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Canada
Health Canada · 141 registrations
- Accel-Ondansetron4 MG · Tablet · Accel Pharma INC
- Accel-Ondansetron8 MG · Tablet · Accel Pharma INC
- Accel-Ondansetron ODT8 MG · Tablet (Orally-Disintegrating) · Accel Pharma INC
- Accel-Ondansetron ODT4 MG · Tablet (Orally-Disintegrating) · Accel Pharma INC
Brazil
Anvisa · 90 registrations
At a glance
- ATC code
- A04AA01
- ATC group
- Alimentary tract and metabolism
- Registers
- 9
- Historical lists
- 3
- Registrations
- 416
- With their own page
- 271
- Companies
- 173
All medicines with Ondansetron
Human medicines from every register that match Ondansetron by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
422 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Ondansetron | United States | 16MG, 24MG, 4MG … | tablet, orally disintegrating | Marketed | Nesher Pharms |
| Ondansetron | United States | 4MG/2ML | injectable | Marketed | Am Regent |
| Ondansetron | Canada | 4 MG | Tablet | Marketed | Sanis Health INC |
| Ondansetron | Canada | 8 MG | Tablet | Marketed | Sivem Pharmaceuticals Ulc |
| Ondansetron | Canada | 4 MG | Tablet | Marketed | Sivem Pharmaceuticals Ulc |
| Ondansetron | Canada | 8 MG | Tablet | Marketed | Sanis Health INC |
| Ondansetron | Canada | 8 MG | Tablet | Marketed | Pro Doc Limitee |
| Ondansetron | Canada | 4 MG | Tablet | Authorised | Pro Doc Limitee |
| Ondansetron ODT | Canada | 4 MG | Tablet (Orally-Disintegrating) | Marketed | Sandoz Canada Incorporated |
| Ondansetron ODT | Canada | 4 MG | Tablet (Orally-Disintegrating) | Marketed | Sanis Health INC |
| Ondansetron ODT | Canada | 8 MG | Tablet (Orally-Disintegrating) | Marketed | Jamp Pharma Corporation |
| Ondansetron ODT | Canada | 4 MG | Tablet (Orally-Disintegrating) | Marketed | Jamp Pharma Corporation |
| Ondansetron ODT | Canada | 8 MG | Tablet (Orally-Disintegrating) | Marketed | Sanis Health INC |
| Ondansetron ODT | Canada | 8 MG | Tablet (Orally-Disintegrating) | Marketed | Sandoz Canada Incorporated |
| Ondansetron ODT | Canada | 8 MG | Tablet (Orally-Disintegrating) | Authorised | Sivem Pharmaceuticals Ulc |
| Ondansetron ODT | Canada | 4 MG | Tablet (Orally-Disintegrating) | Authorised | Sivem Pharmaceuticals Ulc |
| ondansetrona | Brazil | Authorised | Ranbaxy Farmacêutica Ltda | ||
| ondansetrona | Brazil | Authorised | Cimed Industria S.A | ||
| ondansetrona | Brazil | Authorised | Blau Farmacêutica S.A. | ||
| ondansetrona | Brazil | Authorised | Vitamedic Industria Farmaceutica Ltda | ||
| ondansetrona | Brazil | Authorised | DR. Reddys Farmacêutica do Brasil Ltda | ||
| Ondansetron PEYTON | Serbia | 4mg/2mL | rastvor za injekciju | Authorised | Peyton Medical D.O.O. |
| Ondansetron PEYTON | Serbia | 4mg/2mL | rastvor za injekciju | Authorised | Peyton Medical D.O.O. |
| Ondansetron Hydrochloride | United States | 16MG, 16MG BASE, 24MG BASE … | tablet | Marketed | Chartwell RX |
| Ondansetron Hydrochloride | United States | 4MG BASE/5ML | solution | Marketed | Hikma |



